INDENA SPA

Their core work

Indena is a Milan-based industrial manufacturer specializing in the identification, development, and large-scale production of active compounds derived from plants — botanical extracts used in pharmaceuticals, nutraceuticals, and personal care products. Their core competence is taking raw plant material and turning it into standardized, quality-controlled actives that meet regulatory requirements for industrial use. In EU research projects, they function as the industrial bridge between academic plant science and market-ready applications, contributing extraction know-how, quality benchmarking, and scale-up expertise. Their dual participation in bioeconomy crop projects and ethnobotany/pharmacognosy projects reflects a company that sources both commodity biomass and high-value medicinal plants.

What they specialise in

How they've shifted over time

In their earlier H2020 engagement (GRACE, starting 2017), Indena's focus was on biomass and biorefinery feedstocks — hemp, miscanthus, underutilized crops on marginal land — reflecting interest in sustainable raw material supply chains for their extraction operations. By 2019, their second project (EthnoHERBS) shifted sharply toward pharmacognosy, ethnobotany, and skin-active herbal extracts, moving from commodity biomass toward high-value medicinal plant chemistry. The trend is a clear move up the value chain: from biobased feedstock sourcing toward scientifically validated, application-specific botanical actives.

Indena is moving toward ethnobotany-informed, high-value extract development — making them an increasingly relevant partner for projects at the intersection of biodiversity, traditional knowledge, and functional ingredient science.

How they like to work

Indena participates exclusively as a consortium member and has never coordinated an H2020 project — consistent with a large industrial company that contributes specialist manufacturing and quality expertise rather than leading research agendas. With 42 unique partners across 14 countries from just two projects, they operate in large, multidisciplinary consortia where their industrial scale-up capabilities are a valued but non-leading contribution. This suggests they are a reliable, well-networked participant who brings industrial credibility to research proposals without taking on project management risk.

Indena has built a surprisingly broad network of 42 unique partners across 14 countries from only two projects, indicating participation in large, geographically diverse consortia. No single-country concentration is evident from the data, pointing to a genuinely European collaborative footprint.

What sets them apart

Indena occupies a rare position in EU research: a large private-sector botanical extract manufacturer with genuine industrial production capacity, not merely a research lab or consultancy. Where academic partners contribute scientific knowledge of plants, Indena can validate industrial feasibility, supply chain viability, and regulatory readiness — making them particularly valuable in projects that need to demonstrate a route to market. For a consortium building around plant-derived ingredients, cosmeceuticals, or natural pharmaceuticals, Indena brings both credibility with industry reviewers and direct commercial application channels.

Highlights from their portfolio

• EthnoHERBS
  A long-duration MSCA-RISE project (2019–2025) linking European biodiversity conservation directly to commercial herbal extract applications and skin disorder treatments — precisely aligned with Indena's pharmaceutical and personal care product portfolio.
• GRACE
  The only project with recorded EC funding (EUR 271,250), this Innovation Action explored hemp and miscanthus as industrial biorefinery feedstocks on marginal land, representing Indena's interest in sustainable raw material sourcing at scale.